GlassScriptPhysician profile
Charles C Farmer
NPI 1245664440
$9,167.09
in general payments reported to CMS, 2019-2025
48 companies · $2,222 in 2025
The $2,222 reported for 2025 was more than what 78% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.00 · 2022: $485 · 2023: $4,189 · 2024: $2,251 · 2025: $2,222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,066 · Travel and Lodging: $1,539 · Education: $57.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,065.88 |
| Travel and Lodging | $1,538.61 |
| Education | $57.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,006.64 | 2023 | Minimed 780g |
| Lilly USA, LLC | $862.58 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Xeris Pharmaceuticals, INC. | $606.10 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $510.26 | 2023-2025 | |
| Novo Nordisk INC | $468.99 | 2022-2025 | Ozempic, Rybelsus, Tresiba |
| Abbott Laboratories | $406.93 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Ascendis Pharma Endocrinology INC | $363.34 | 2023-2025 | Yorvipath, Skytrofa |
| Insulet Corporation | $320.07 | 2023-2025 | Omnipod, Omnipod |
| Radius Health, INC. | $292.00 | 2023-2025 | Tymlos |
| Tandem Diabetes Care, INC. | $263.32 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.33 | 2022-2025 | Jardiance, Synjardy, Tradjenta |
| Corcept Therapeutics | $258.71 | 2022-2025 | Korlym |
| Beta Bionics, INC. | $219.97 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ibsa Pharma INC. | $210.96 | 2022-2025 | Tirosint, Licart, Tirosint |
| Azurity Pharmaceuticals, INC. | $206.54 | 2023-2025 | Triptodur, Triptodur |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $202.53 | 2023-2025 | Isturisa, Signifor Lar |
| Alexion Pharmaceuticals, INC. | $135.27 | 2023-2025 | Strensiq |
| Dexcom, INC. | $122.40 | 2023-2025 | Dexcom G6 Transmitter |
| Mannkind Corporation | $108.46 | 2025 | |
| Pfizer INC. | $99.41 | 2023-2025 | |
| Cequr Corporation | $90.37 | 2024-2025 | Cequr Simplicity |
| Kyowa Kirin, INC. | $87.95 | 2023-2025 | Crysvita |
| Abbvie INC. | $86.10 | 2022-2024 | |
| Amneal Pharmaceuticals LLC | $77.39 | 2023-2025 | Unithroid |
| Sequel Med Tech, LLC | $61.16 | 2025 | Twiist |
| Eton Pharmaceuticals, INC. | $60.61 | 2024-2025 | Alkindi, Increlex, Khindivi |
| Bayer Healthcare Pharmaceuticals INC. | $60.20 | 2023 | |
| Madrigal Pharmaceuticals | $58.98 | 2024-2025 | Rezdiffra, Resmetirom |
| Amgen INC. | $57.26 | 2023-2025 | Evenity, Prolia, Prolia |
| Neurocrine Biosciences, INC. | $50.80 | 2024-2025 | |
| Esperion Therapeutics, INC. | $45.48 | 2024 | Nexletol |
| Astellas Pharma US INC | $45.04 | 2024-2025 | Veozah |
| Amphastar Pharmaceuticals, INC. | $44.95 | 2024 | |
| Soleno Therapeutics, INC. | $42.75 | 2025 | Vykat Xr |
| Astrazeneca Pharmaceuticals LP | $39.37 | 2023 | Evusheld |
| Halozyme INC | $36.44 | 2023 | |
| Novartis Pharmaceuticals Corporation | $36.03 | 2025 | |
| Nevro Corp. | $33.48 | 2024 | Senza |
| Antares Pharma, INC. | $32.42 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Tolmar, INC. | $31.83 | 2023-2025 | Fensolvi |
| Amryt Pharma Holdings LTD | $23.73 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $23.64 | 2023 | |
| Shield Therapeutics INC | $21.76 | 2024 | |
| Endo USA, INC. | $20.85 | 2025 | Supprelin |
| Celgene Corporation | $20.00 | 2019 | |
| Intuity Medical INC | $18.45 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Chiesi USA, INC. | $18.44 | 2025 | Myalept |
| Rhythm Pharmaceuticals, INC. | $16.80 | 2024 | Imcivree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.